Terms: = Bone cancer AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Diagnosis
6 results:
1. LncRNA malat1-related signaling pathways in osteosarcoma.
Farzaneh M; Najafi S; Anbiyaee O; Azizidoost S; Khoshnam SE
Clin Transl Oncol; 2023 Jan; 25(1):21-32. PubMed ID: 35790599
[TBL] [Abstract] [Full Text] [Related]
2. [Relationship between long non-coding RNA malat1 and prostate cancer].
Zhang F; Wu CF; Luo YH; Zhou FH
Zhonghua Nan Ke Xue; 2020 Feb; 26(2):174-179. PubMed ID: 33346423
[TBL] [Abstract] [Full Text] [Related]
3. Knockdown of malat1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.
Duan G; Zhang C; Xu C; Xu C; Zhang L; Zhang Y
Int J Oncol; 2019 Jan; 54(1):17-28. PubMed ID: 30365098
[TBL] [Abstract] [Full Text] [Related]
4. A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/malat1/PTCH1-GLI1 Fusions.
Antonescu CR; Agaram NP; Sung YS; Zhang L; Swanson D; Dickson BC
Am J Surg Pathol; 2018 Apr; 42(4):553-560. PubMed ID: 29309307
[TBL] [Abstract] [Full Text] [Related]
5. Long non-coding RNAs: emerging players in osteosarcoma.
Li Z; Yu X; Shen J
Tumour Biol; 2016 Mar; 37(3):2811-6. PubMed ID: 26718212
[TBL] [Abstract] [Full Text] [Related]
6. malat1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression.
Cho SF; Chang YC; Chang CS; Lin SF; Liu YC; Hsiao HH; Chang JG; Liu TC
BMC Cancer; 2014 Nov; 14():809. PubMed ID: 25369863
[TBL] [Abstract] [Full Text] [Related]
